Rxsight
Yahoo Finance • 8 months ago
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
A week ago, RxSight, Inc. (NASDAQ:RXST) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. Revenues beat expectations coming in atUS$30m, ahead of estimates by 7.1%. Statutory losses were... Full story
Yahoo Finance • 9 months ago
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
RxSight, Inc. ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today... Full story
Yahoo Finance • last year
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced tha... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Present at the Needham Healthcare Conference
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced pl... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced tha... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. Announces Proposed Public Offering of Common Stock
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)– RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it intends to offer... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results
ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary una... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in t... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report finan... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in t... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program
ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it has filed a $20... Full story
Yahoo Finance • 2 years ago
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022
ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report fin... Full story
Yahoo Finance • 3 years ago
RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate... Full story
Yahoo Finance • 3 years ago
RxSight, Inc. to Report First Quarter 2022 Financial Results on May 5, 2022
ALISO VIEJO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – April 21, 2022 – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that... Full story
Yahoo Finance • 3 years ago
Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that its Light Adjus... Full story
Yahoo Finance • 3 years ago
RxSight, Inc. to Present at the Needham Virtual Healthcare Conference
ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate... Full story
